Open Actively Recruiting

Advancing Prevention of Pulmonary Fibrosis

About

Brief Summary

This study plans to learn more about pulmonary fibrosis and how it develops. We want to determine if the disease can be detected early, before the lung is permanently scarred.

This study will enroll participants who are not currently diagnosed with pulmonary fibrosis, but who have family members with pulmonary fibrosis. Because there is an increased risk within affected families, this cohort will allow us to learn how pulmonary fibrosis develops, and how the lungs change over time.

Study Type
Observational
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
Yes
Minimum Age
40 Years
Maximum Age
75 Years

Inclusion Criteria:

  • Unaffected first degree relative from Familial Interstitial Pneumonia families (two or more family members with IIP)
  • Age at least 40 years old and younger than 75 years old

Exclusion Criteria:

  • Diagnosed with known (physician-diagnosed) pulmonary fibrosis prior to informed consent
  • Other genetic diseases associated with interstitial lung disease
  • Pregnant women

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
22-000302
Category
Genetic and Rare Diseases
Contact
Paul Lopez Jr
Location
  • UCLA Westwood
For Providers
NCT No.
NCT04564183
For detailed technical eligibility, visit ClinicalTrials.gov.